中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
2期
75-76
,共2页
诱导化疗%放疗%中晚期鼻咽癌%价值
誘導化療%放療%中晚期鼻嚥癌%價值
유도화료%방료%중만기비인암%개치
Induction chemotherapy%Radiotherapy%Advanced nasopharyngeal carcinoma%Value
目的:分析诱导化疗联合放疗在中晚期鼻咽癌治疗中应用的价值。方法将我院收治的78例中晚期鼻咽癌患者分为对照组和研究组,临床对对照组患者主要采用单纯放疗治疗,而对研究组患者在对照组治疗的基础上加用诱导化疗方法,并观察两组患者治疗的效果。结果研究组患者的中位进展期、中位生存期及生存率较高于对照组,两组比较(P<0.05),差异有统计学意义。结论诱导化疗联合放疗在中晚期鼻咽癌患者治疗中应用,效果显著,近期疗效和远期疗效佳,不良反应少,值得临床推广应用。
目的:分析誘導化療聯閤放療在中晚期鼻嚥癌治療中應用的價值。方法將我院收治的78例中晚期鼻嚥癌患者分為對照組和研究組,臨床對對照組患者主要採用單純放療治療,而對研究組患者在對照組治療的基礎上加用誘導化療方法,併觀察兩組患者治療的效果。結果研究組患者的中位進展期、中位生存期及生存率較高于對照組,兩組比較(P<0.05),差異有統計學意義。結論誘導化療聯閤放療在中晚期鼻嚥癌患者治療中應用,效果顯著,近期療效和遠期療效佳,不良反應少,值得臨床推廣應用。
목적:분석유도화료연합방료재중만기비인암치료중응용적개치。방법장아원수치적78례중만기비인암환자분위대조조화연구조,림상대대조조환자주요채용단순방료치료,이대연구조환자재대조조치료적기출상가용유도화료방법,병관찰량조환자치료적효과。결과연구조환자적중위진전기、중위생존기급생존솔교고우대조조,량조비교(P<0.05),차이유통계학의의。결론유도화료연합방료재중만기비인암환자치료중응용,효과현저,근기료효화원기료효가,불량반응소,치득림상추엄응용。
Objective To analyze the application of induction chemotherapy combined with radiotherapy for advanced nasopharyngeal carcinoma value.Methods Our hospital 78 cases of advanced nasopharyngeal carcinoma patients were divided into control group and study group of patients in the control group, clinical mainly adopts simple radiotherapy, and the study group patients in the control group treated with induction chemotherapy, and to observe the effect of treatment of two groups of patients.Results The median progression study,group the median survival of patients and the survival rate was significantly higher than that in control group,compared the two groups (P<0.05),the difference was statisticaly significant.Conclusion Induction chemotherapy combined with radiotherapy for advanced nasopharyngeal carcinoma patients in the treatment, the effect is significant,the recent and long-term good curative effect, less adverse reactions, it is worthy of clinical application.